Oligoprogressive Disease
Showing 1 - 25 of >10,000
Head Neck Cancer, Metastatic Cancer, Oligoprogressive Trial in Montréal (Standard arm, Experimental arm)
Recruiting
- Head and Neck Cancer
- +2 more
- Standard arm
- Experimental arm
-
Montréal, Quebec, CanadaCentre Hospitalier de l'Université de Montréal
Mar 6, 2022
Oligometastatic Disease, Prostatic Cancer, Castration-Resistant Trial in Dresden (local ablative radiotherapy)
Recruiting
- Oligometastatic Disease
- Prostatic Cancer, Castration-Resistant
- local ablative radiotherapy
-
Dresden, Saxony, GermanyDepartment of Radiotherapy and Radiation Oncology, Faculty of Me
Aug 18, 2021
TNBC - Triple-Negative Breast Cancer, Triple Negative Breast Cancer, NSCLC Trial in United States (Sterotactic Body
Active, not recruiting
- TNBC - Triple-Negative Breast Cancer
- +6 more
- Sterotactic Body Radiotherapy/SBRT
- Standard of care
-
Basking Ridge, New Jersey
- +8 more
Jul 26, 2022
Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in Duarte, New Haven (procedure, drug, radiation, other)
Not yet recruiting
- Lung Non-Small Cell Carcinoma
- Stage IV Lung Cancer AJCC v8
- Biospecimen Collection
- +5 more
-
Duarte, California
- +1 more
Aug 24, 2023
Lung Adenocarcinoma, Lung Tumors Trial run by the NCI (osimertinib, LAT)
Completed
- Lung Adenocarcinoma
- Lung Neoplasms
- osimertinib
- LAT
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Oct 17, 2022
NSCLC, Oligoprogressive, Small-cell Lung Cancer Trial in Sacramento (Ablative local therapy)
Recruiting
- Non-small Cell Lung Cancer
- +2 more
- Ablative local therapy
-
Sacramento, CaliforniaUniversity of California, Davis
Oct 27, 2023
NSCLC Stage IV Trial in Hangzhou (SBRT)
Recruiting
- NSCLC Stage IV
- SBRT
-
Hangzhou, Zhejiang, ChinaZhejiang Cancer Hospital
May 22, 2022
Ovarian Cancer Recurrent Trial in Sutton, London (Niraparib oral capsule, SBRT)
Not yet recruiting
- Ovarian Cancer Recurrent
- Niraparib oral capsule
- SBRT
-
Sutton, Surrey, United Kingdom
- +1 more
Aug 10, 2023
Lung Non-Small Cell Carcinoma, Malignant Solid Tumor, Melanoma Trial in Duarte (procedure, other, radiation)
Not yet recruiting
- Lung Non-Small Cell Carcinoma
- +3 more
- Biospecimen Collection
- +4 more
-
Duarte, CaliforniaCity of Hope Medical Center
Apr 13, 2023
NSCLC, EGFR Positive NSCLC, Oligoprogression Trial in München (Osimertinib, Radiotherapy)
Recruiting
- NSCLC
- +2 more
- Osimertinib
- Radiotherapy
-
München, GermanyLMU Klinikum der Universität München
May 17, 2022
Oligorecurrent and Oligoprogressive Prostate Cancer Patients Trial in Rozzano (procedure, drug, biological)
Recruiting
- Oligorecurrent and Oligoprogressive Prostate Cancer Patients
- Radiotherapy
- +2 more
-
Rozzano, Milano, ItalyHumanitas Research Hospital
May 3, 2022
NSCLC Stage IV, EGFR Gene Mutation Trial in Worldwide (Osimertinib, Stereotactic Body Radiation Therapy (SBRT))
Recruiting
- NSCLC Stage IV
- EGFR Gene Mutation
- Osimertinib
- Stereotactic Body Radiation Therapy (SBRT)
-
Alessandria, Italy
- +15 more
Mar 29, 2022
NSCLC With Mutation in Epidermal Growth Factor Receptor Trial in Leuven (Local ablative therapy)
Recruiting
- Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor
- Local ablative therapy
-
Leuven, BelgiumUZLeuven
Oct 21, 2021
Stage III Lung Cancer AJCC v8, Stage III Lung Non-Small Cell Cancer AJCC v7, Stage IIIA Lung Cancer AJCC v8 Trial in Houston
Not yet recruiting
- Stage III Lung Cancer AJCC v8
- +6 more
- Carboplatin
- +8 more
-
Houston, TexasM D Anderson Cancer Center
May 14, 2021
NSCLC Stage IV Trial in Shanghai (PD-1 Blockade, SBRT)
Recruiting
- NSCLC Stage IV
- PD-1 Blockade
- SBRT
-
Shanghai, ChinaFudan University Shanghai Cancer Center
Feb 19, 2021
Metastatic Prostate Cancer, Castration-resistant Prostate Cancer Trial in Montréal (Darolutamide (BAY1841788), SBRT)
Recruiting
- Metastatic Prostate Cancer
- Castration-resistant Prostate Cancer
- Darolutamide (BAY1841788)
- SBRT
-
Montréal, Quebec, CanadaSir Mortimer JGH
Sep 20, 2021
Oligoprogressive, Castration-Resistant Prostate Cancer Trial in Toronto (Stereotactic Body Radiation Therapy (SABR))
Recruiting
- Oligoprogressive
- Castration-Resistant Prostate Cancer
- Stereotactic Body Radiation Therapy (SABR)
-
Toronto, Ontario, CanadaOdette Cancer Centre
Apr 9, 2021
Oligometastatic Prostate Cancer Trial in New York (Quemliclustat, Etrumadenant, Zimberelimab)
Not yet recruiting
- Oligometastatic Prostate Cancer
- Quemliclustat
- +3 more
-
New York, New YorkColumbia University Irving Medical Center / NewYork-Presbyterian
Jun 14, 2023
NSCLC, Oligoprogressive Trial in Guangzhou (Furmonertinib)
Recruiting
- Non-small Cell Lung Cancer
- Oligoprogressive
-
Guangzhou, Guangdong, ChinaSun yat-sen University Cancer Center
Jul 10, 2021
Breast Cancer, Oligoprogressive, Head Neck Cancer Trial in Sacramento (Ablative local therapy)
Recruiting
- Breast Cancer
- +4 more
- Ablative local therapy
-
Sacramento, CaliforniaUniversity of California, Davis
Oct 19, 2023
Prostate Cancer, Oligoprogressive, Urothelial Carcinoma Trial in Sacramento (Ablative local therapy)
Recruiting
- Prostate Cancer
- +3 more
- Ablative local therapy
-
Sacramento, CaliforniaUniversity of California, Davis
Oct 19, 2023
Esophageal Cancer, Small Bowel Cancer, Gastroesophageal-junction Cancer Trial in Sacramento (Ablative local therapy)
Recruiting
- Esophageal Cancer
- +10 more
- Ablative local therapy
-
Sacramento, CaliforniaUniversity of California, Davis
Oct 27, 2023
Primary Breast Oligoprogressive Sites Treated With Radiotherapy
Not yet recruiting
- Breast Carcinoma
- Non-Interventional Study
-
Scottsdale, Arizona
- +2 more
Sep 26, 2023